Putting patients first

IQVIA PES helps address some of the most persistent challenges in patient care and commercialization, including delayed diagnosis, complex access and reimbursement processes, affordability constraints, and poor long‑term adherence.

Our solutions are designed to reduce friction at every step, enabling patients to start therapy faster and stay on treatment longer—while delivering measurable impact for brands.

IQVIA PES includes awareness and screening, access and reimbursement support, affordability programs, and treatment adherence services:

• Awareness, Activation & Screening – Helping identify and engage the right patients earlier, reducing diagnostic delays and strengthening referral pathways
• Access & Reimbursement – Simplifying benefits verification, prior authorization, and reimbursement to accelerate time‑to‑treatment
• Affordability & Financial Assistance – Supporting patients with co‑pay programs, free goods, and financial solutions to overcome cost barriers
• Treatment Support & Adherence – Providing ongoing education, coaching, and human support to help patients stay on therapy

IQVIA delivers insight‑driven patient engagement designed around the patient experience.

We combine unmatched data and analytics, behavioral science, advanced technology, and global execution—backed by market‑leading compliance—to deliver personalized programs with measurable impact for patients and brands.

IQVIA combines advanced analytics, AI‑driven insights, and behavioral science with human touchpoints such as nurse educators, care coordinators, and global contact centers.

This enables personalized engagement tailored to each patient’s needs, preferences, and barriers—while remaining scalable across therapy areas, geographies, and patient populations.

IQVIA Patient Engagement and Support operates across multiple therapy areas and indications, supporting diverse patient populations and health systems globally.

With delivery in 45+ countries, IQVIA combines global scale with localized expertise to adapt programs to regional requirements and patient needs.

Yes. IQVIA PES is built on a strong foundation of compliance, pharmacovigilance, safety reporting, and risk management expertise.

All programs are designed and delivered in accordance with local and global regulatory requirements, ensuring patient safety, data protection, and program integrity across markets.

Getting started begins with a conversation. IQVIA works as a strategic partner, collaborating with brand, market access, and commercial teams to design tailored patient engagement solutions aligned to specific challenges, therapy goals, and market realities. From pilot programs to global scale‑up, IQVIA supports every step of the journey.